Showcases Stock ranks

AstraZeneca PLC (AZN)
53.8  0.48 (0.9%) 07-02 16:00
Open: 53.63 Pre. Close: 53.32
High: 54.07 Low: 53.46
Volume: 4,573,405 Market Cap: 140,555M
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Q
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 54.14 - 54.359 54.359 - 54.567
Low: 52.909 - 53.155 53.155 - 53.389
Close: 53.421 - 53.802 53.802 - 54.165
Stock Technical Analysis
Target: Six months: 64.95
One year: 75.86
Support: Support1: 52.73
Support2: 50.95
Resistance: Resistance1: 55.61
Resistance2: 64.95
Pivot: 53.05
Moving Averages: MA(5): 53.13
MA(20): 53.00
MA(100): 49.33
MA(250): 47.44
MACD: MACD(12,26): 0.10
Signal(12,26,9): 0.10
%K %D: %K(14,3): 56.37
%D(3): 50.03
RSI: RSI(14): 54.25
52-Week: High: 57.44
Low: 36.15
Change(%): 31.8
Average Vol(K): 3-Month: 496905
10-Days: 576471
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

AZN has closed below upper band by 22.2%. Bollinger Bands are 56.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to AZN's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Tue, 09 Jun 2020
Here is What Hedge Funds Think About AstraZeneca plc (AZN) - Yahoo Finance

Tue, 16 Jun 2020
Is AstraZeneca (AZN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mon, 29 Jun 2020
AstraZeneca Strikes $127 Million Deal With Brazil For Covid-19 Vaccine - Yahoo Finance

Fri, 26 Jun 2020
What are AstraZeneca plc (AZN) Stock's Trading Patterns? - InvestorsObserver

Mon, 15 Jun 2020
Is AstraZeneca plc (AZN) Stock Worth a Buy Monday? - InvestorsObserver

Mon, 08 Jun 2020
AstraZeneca and Gilead Sciences merger hard to square say analysts - Proactive Investors USA & Canada

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug ManufacturersGeneral
Shares Out. (M) 2620.00
Shares Float (M) 2620.00
% Held by Insiders
% Held by Institutions 18.47
Shares Short (K) 3170
Shares Short Prior Month (K) 3560
Stock Financials
EPS 0.580
Book Value (p.s.) 4.110
Profit Margin 6.03
Operating Margin 13.48
Return on Assets (ttm) 3.6
Return on Equity (ttm) 11.7
Qtrly Rev. Growth 15.7
Gross Profit (p.s.) 7.458
Sales Per Share 9.637
EBITDA (p.s.) 2.279
Qtrly Earnings Growth 31.50
Operating Cash Flow (M) 3500.00
Levered Free Cash Flow (M) 4130.00
Stock Valuation
PE Ratio 92.78
PEG Ratio 1.49
Price to Book value 13.09
Price to Sales 5.58
Price to Cash Flow 40.28
Stock Dividends
Dividend 2.800
Dividend Yield 0.05
Dividend Growth 1.400

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator